VS

Vivek Singh

Active Director Director DIN 08482657
DIN 08482657 First appointment Jun 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Vivek Singh

Data last updated:

Vivek Singh is a Director at Ajchem Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Ajchem Pharmaceuticals Private Limited reported revenue of ₹99,658 (FY 2024).

DIN 08482657
Primary Designation Director
Industry Trading
First Appointment 14 Jun 2019
Oldest Company Age 7 yrs
Largest company Ajchem Pharmaceuticals Private Limited · ₹99,658 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jun 20192019₹99,658 (FY 2024)Active

Board colleagues of Vivek Singh

NameDINCompanyDesignation
Rahul Singh08482656Ajchem Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ajchem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vivek Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Singh

Vivek Singh currently holds 1 directorship: Ajchem Pharmaceuticals Private Limited (Director, since 14 Jun 2019, revenue ₹99,658 (FY 2024)).

Vivek Singh was first appointed on 14 Jun 2019 as Director at Ajchem Pharmaceuticals Private Limited.

The current boards of Vivek Singh's companies include Rahul Singh (Ajchem Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available